Lending in pennyland for the past 2-3 years has dried UP. Get used to more & more penny stock companies to do a r/s if they're looking for funding. Jim made it sound like once he had the toxicity report and CRO partnership that the initial funds for clinical trials is lined up, 🤣 and if trial results have positive results, who wouldn't want to lend the company $$ at that point to move forward. 🤣 🤣
So far, he's got nada but a story and lots of folks here call it a BS story.